Centre for NanoHealth Swansea University www.nanohealth.swansea.ac.uk Centre for NanoHealth Future Healthcare Dr Steve Conlan Director - Centre for NanoHealth.

Slides:



Advertisements
Similar presentations
Engaging with Employers UKSPA Member Meeting Oct 6th/7th John Holton Strategy Director Cogent Sector Skills Council.
Advertisements

Meaningful Patient Involvement In FP7 Research Nicola Bedlington Meaningful Patient Involvement In FP7 Research Nicola Bedlington Open Information Day.
Making Innovation Affordable Jo Derbyshire European Commercial Manager
Senate Education Committee Briefing Russell Ingram, Executive Director March 23, 2011.
Institute of Life Science Phase Two Professor Gareth Morgan Head of School.
ESIF Priority Areas and Detailed Design Workshop Tuesday 2 December 2014 Sheffield Hallam University The Sheffield City Region and Innovation Yasmin Knight,
CUHP Cambridge University Health Partners (CUHP) unites a world-leading University and three high- performing NHS Foundation Trusts centred on the Cambridge.
Driving Innovation Concept to Commercialisation A strategy for business innovation, Zahid Latif Head of Healthcare Mark Glover 12 th January.
Bindley Bioscience Center Vision: Nurture interactive communication and interdisciplinary discovery with flexible laboratory project spaces and an open.
Engaging regional health systems in the knowledge economy: lessons learnt so far Professor Jonathan Watson PhD FRSM HCN Executive Director EUREGIO III.
Health Stakeholder Consultation Event Frances Spillane, Assistant Secretary General Department of Health 11 March 2015.
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
1 Presentation title - edit in the Master slide 1 Current Investment Opportunities Professor Rory Shaw, Medical Director, Healthcare UK, UKTI.
The South African Malaria Initiative A Case Study E Jane Morris Bridging the Gap in Global Health Innovation - from Needs to.
GATEWAY TO FINNISH EXPERTISE 1 Commercialization guidelines – NanoCom and ProNano results Dr. Eeva Viinikka, Business Director Programme Director of National.
Cornell University International Healthcare Conference 11 th - 12 th May 2010 Staff involvement as a matter of life and death? Participative governance.
The Outreach Project “Helping NW companies access fund for R&D” Lesley Lambert General Engineering Research Institute Liverpool John Moores University.
Institute of Life Science Phase 2 Project Overview School Staff Assembly 10 th June 2009.
Sector Specific Investment Promotion - Ireland Barry O’Leary CEO, IDA Ireland May 3 rd 2013.
Working across sectors Building collaborative eco-systems Lars Sundstrom SARTRE.
WEFO’s Horizon 2020 Unit: supporting Welsh organisations Geraint Green Head of Horizon 2020 Unit Welsh European Funding Office.
Florida Center of Excellence for Biomolecular Identification and Targeted Therapeutics.
Access to Clinical Expertise Steve Bain David Powell Jemma Hughes Paula Jeffries.
Wales Infrastructure Investment Plan Gerald Holtham Adviser to Welsh government.
Image 1 – Tomato seedling iStockphoto/Thinkstock, Image 2 – Fermenter iStockphoto/Thinkstock 2011, Image 3 – Wheat Hermerara/Getty Images, Image 4 –DNAConfig.
Innovation Pathway AHSN Stakeholder Event Russ Watkins Assistant Director – Business Innovation & Improvement Newcastle Hospitals.
Dr. José M. Millán, PhD Deputy Director of CIBERER Universitary Hospital La Fe, Valencia, Spain Barriers and Challenges in Rare Diseases Research Centre.
Where to focus? Horizon 2020 'Health, demographic change and wellbeing' Open Info Day -Horizon 2020 'Health, demographic change and wellbeing' Brussels,
The Role of Research in Osteopathic Medical Education American Association of Colleges of Osteopathic Medicine June 25, 2004 David B. Moore Associate Vice.
Technology Strategy Innovation Platforms Allan Mayo Technology Strategy Directorate DTI.
Science and Technology Business Incentive Programs New Jersey Commission on Science and Technology Peter R. Reczek, Ph. D. Executive Director.
September 13, 2007SGH&M2B International&Training Workshop What does the European Technology Platform “Innovative Medicines initiative” offer? Vitalijs.
Business Development Team. Speakers Chris Mountford Business Development Executive Alexandra Cassidy Commercial Relations Executive.
Research in the Global Society Ian Diamond ESRC. THE RESEARCH COUNCILS Arts and Humanities Research Council Biotechnology and Biological Sciences Research.
How Green is my university? Sustainability in HE in Wales EAUC Conference 24th March 2010 Professor Phil Gummett Chief Executive.
The South East Wales Academic Health Science Partnership Dr Corinne Squire Manager SEWAHSP.
NHS engagement with the EU NHS Confederation Conference 23 June 2010.
The European Innovation Partnership for asthma: an opportunity for change Samantha Walker PhD, Asthma UK Project Coordinator, EARIP (European Asthma Research.
1 Overview of EPSRC Strategy The Future of HCI in the UK 14 th June 2007 Claire Hinchliffe.
Innovating out of the recession in the NHS Steve Barnett, Chief Executive NHS Confederation 28 th October 2009 Foundation Trust Network - Primary Care.
Research Councils UK Investing in Excellence with Impact Alexandra Saxon Head of RCUK Strategy Unit.
WELSH EUROPEAN FUNDING OFFICE SMEs Innovation Development in Wales Strategy & Experience 13 October 2005 Dr. Emyr Roberts Chief Executive.
HEInnovate A self-assessment tool for higher education institutions (HEIs) wishing to explore their entrepreneurial and innovative potential.
Access to drugs, Reducing bottlenecks Matt Cooper Business Development & Marketing Director NIHR Clinical Research Network
Emily Nott Relationship Manager - Research Councils IT Community Summit 3 April 2008 Technology Strategy Board V
Higher Education Policies: Challenges and Opportunities Prof. David Taylor Pro Vice-Chancellor (International)
Practical Aspects of Preparation FP 6 projects Senter/EG-Liaison Nationaal Contact Punt voor het 6de Kaderprogramma Sandra de Wild 11 december 2002.
European Structural and Investment Funding (ESIF) AHSN ESIF/ LEP knowledge sharing webinar 24 February 2016.
NHS Confederation Annual Conference 4 June Matching Health with Growth – the UHB Story.
Opportunities in 2012 and Beyond The Way Forward Stuart Semple Director of Pharmacy and Medicines Management Barts Health NHS Trust.
NoWCADD Progress Report 2015
Horizon 2020 Overview Jerome de Barros NCP Health.
Roadmap Economic Impact & Funding Opportunities Dr Stephen Hillier
Systemic change by streamlined innovation: personalised medicine Novembre 8, 2013.
NISCHR Academic Health Science Collaboration Launch Millennium Stadium Cardiff 3 March 2011.
NERC Innovation Oil & Gas Challenging Environments Workshop 17 th October 2014.
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
North Somerset Partnership Priorities & Opportunities 2 December 2015.
A Brief Introduction to The Energy Technology Partnership.
Guidance notes These slides are intended to support staff who are making presentations about the University and have been designed to complement the University’s.
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Centre for Environment, Fisheries and Aquaculture Science “Cefas is a world leader in marine science and technology, providing innovative solutions for.
Nurturing Growth in Healthcare
A Centre for New Methods in Computational Diagnostics and Personalised Therapy This EU H2020 ‘Teaming for Excellence’ project develops a Business Case.
From Bench to Clinical Applications: Money Talks
Welsh Health Innovation Technology Accelerator
Innovative Medicines Initiative:
“Israel’s capacity for science and research will be tested in the Negev" David Ben-Gurion, Israel's first Prime Minister(1958)
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Prof. Kiran Kalia, Director NIPER Ahmedabad
Presentation transcript:

Centre for NanoHealth Swansea University Centre for NanoHealth Future Healthcare Dr Steve Conlan Director - Centre for NanoHealth Institute of Life Science School of Medicine

Centre for NanoHealth Swansea University Overview Nanotechnology NanoHealth Impact of NanoHealth Centre for NanoHealth Challenges and Opportunities R&D

Centre for NanoHealth Swansea University Please turn off your Nanotechnology based devices.

Centre for NanoHealth Swansea University The nano-scale

Centre for NanoHealth Swansea University What is NanoHealth?

Centre for NanoHealth Swansea University Ability to manipulate and control the properties and interaction of material where at least 1-D is nm. Structural Mechanical Electronic Optical Chemical Biological Computational Modelling Nanotechnology… Multidisciplinary …For Healthcare

Centre for NanoHealth Swansea University The impact of NanoHealth

Centre for NanoHealth Swansea University NanoHealth… … has the potential to impact on the prevention, early and reliable diagnosis and treatment of diseases. European Technology Platform on NanoMedicine Vision Paper (2005) NanoHealth embraces five main sub-disciplines that in many ways are overlapping Analytical Tools Imaging Tools Materials and Devices Novel Therapeutics and Drug Delivery Systems: ‘Nanomedicines’ Clinical, Regulatory and Toxicological Issues ESF forward look on Nanomedicine (2005)

Centre for NanoHealth Swansea University Diagnosing and treating diseases Enhancing early intervention Non-hospital environments Personalised Medicine Impact on Healthcare

Centre for NanoHealth Swansea University Economic Impact

Centre for NanoHealth Swansea University Economic Impact

Centre for NanoHealth Swansea University Global Networks/Global Investment EU, US, South America and Asia Alliance for Nanohealth ETP for Nanomedicine

Centre for NanoHealth Swansea University Centre for NanoHealth

Centre for NanoHealth Swansea University Partnership for Success Institute of Life Science £52m collaborative venture between IBM, Swansea University, WAG, opening its doors in 2007 Home in the Medical School, 25 specialist teams (27 Professors and 220 Research active staff) Multidisciplinary Nanotechnology Centre More than £5M funding in 2002 from HEFCW, Royal Society/ Wolfson Foundation, SRIF and Swansea University Home in Engineering, major research centre (20 academic staff, 20 RAs and 40 PhD students) Outstanding RAE 2008 results (THES) MNC 5 th out of 52 in UK in General Engineering, 80% of activity rated 4* and 3* ILS 7 th out of 70 in UK in Allied and Professional Health, 55% of activity 4* and 3*

Centre for NanoHealth Swansea University Partnership for Success Successfully managed Objective 1 project On time - On budget Outputs met– sustainability/job creation/strong links with business/IP Blue C IBM partnership Interdisciplinary research base University NHS Trust Patient base of 600,000+ Partnership with ILS and MNC Joint MNC and ILS laboratories in Morriston Hospital Commitment to CNH Successfully managed HEFCW project Model interdisciplinary centre Self-sustaining (£2M per year) Strong links with business/IP Pan-Wales focus for nanotech

Centre for NanoHealth Swansea University Centre for NanoHealth £22M EU Convergence funded project, started January new staff (8 academic, 4 project management and delivery). £13M investment in state of the art open access nano- and bio-facilities. Industry to come and work with us, access to facilities, expertise and incubation space. Unique interdisciplinary R&D environment Based on the application of Nanotechnology Leading innovations in Healthcare. Driving the Knowledge Economy

Centre for NanoHealth Swansea University Centre for NanoHealth

Centre for NanoHealth Swansea University Project Funding £22 Million, 5 year Knowledge Economy project Supported by: WEFO [£10.5 Million] DHSS [£1.5 Million] Swansea University [£7.6 Million] Industry [£2.5 Million]

Centre for NanoHealth Swansea University CNH Targets & Deliverables Establishing a European R&D Centre of Excellence Assisting 400 Enterprises (>80% Welsh SMEs) Assisting 100 Individuals Creating 450 Jobs Achieving sustainability by 2014 Through Welsh, UK, Industrial and EU funding

Centre for NanoHealth Swansea University Building opens Q Facilities available now CNH Bio-suite NanoToxicology Cell Imaging Tissue Engineering Molecular biology Microbiology Nano-suite Class 100/1000 ‘dirty’ clean room Bio-clean room Nanostructure growth SEM & AFM/SNOM NMR & Rheology Printing and Coating Direct access to: Clinical Trials Unit & Patient imaging (MRI&CT)

Centre for NanoHealth Swansea University Projects challenges & opportunities

Centre for NanoHealth Swansea University Challenges & Opportunities Company recruitment Business development IP State Aid Managing stakeholder expectations Sustainability

Centre for NanoHealth Swansea University Company recruitment & Business development Project must offer real opportunities to businesses across Wales Take the project to the companies Launch Events/BioWales/KTNs etc Initial assistance is only the first step in the relationship Ensure multiple entries for engagement Pool of relevant expertise is essential Awareness of funding opportunities is essential Beware of ERDF overload – internal/institutional management vital

Centre for NanoHealth Swansea University Access Clinical/Biomedical/Engineering teams Fully integrated work flow Access at any stage Translational applications Great opportunities in a new area of healthcare CNH

Centre for NanoHealth Swansea University IP / IPR IP policy of University has to be flexible Case by case consideration – one model DOES NOT fit all Primary consideration to companies – SHOW STOPPER Has to be managed differently to IP generated in house Early negotiation Companies understand and appreciate position of University State Aid compliance

Centre for NanoHealth Swansea University State Aid Necessarily a major consideration under European law Documentation from WEFO offers clarity in their expectations Seek legal advice on wording used in business plans De minimus scheme easy to implement

Centre for NanoHealth Swansea University Sustainability – R&D pipeline Start early Awareness of all opportunities Development pipeline

Centre for NanoHealth Swansea University Delivery = Team work!! Medicine Engineering Finance Research and Innovation Procurement VC’s office ABMUHB External project managers / build team WEFO Early/Continued/Agreed/Managed engagement

Centre for NanoHealth Swansea University CNH operational structure

Centre for NanoHealth Swansea University NanoHealth R&D

Centre for NanoHealth Swansea University

Centre for NanoHealth Swansea University Ultra-sensitive biosensor for the detection of bio-markers using bio-compatible ZnO nanowires. Diagnostics – Biosensors ZnO nanowires (AFM) Novel Materials Antibody Antigen Nanowire Electrode

Centre for NanoHealth Swansea University Surface topography. Material properties. Spatial resolution nm. Cellular Analysis for Clinical Diagnostics

Centre for NanoHealth Swansea University Volume additive printing for the integration of biosensors with flexible polymer electronics, photonics and displays. Biosensors / Biomarker Detection

Centre for NanoHealth Swansea University Centre for NanoHealth

Centre for NanoHealth Swansea University Centre for NanoHealth